Twenty-one patients participated in the study. On average, Prineo closure took 58.38 seconds (2.50 s/cm) while subcuticular closure took 444.76 seconds (18.94 s/cm). Prineo closure was approximately 6.8 times faster (p=0.000) than subcuticular closure, saving an average of 6.4 minutes per incision. VSS scores were significantly better in patients with Prineo closure at 2 weeks (p=0.026), although there was no difference in POSAS and VSS scores at all other time points. No differences were found in wound complication or infection rates between the two groups and no adverse reactions were observed in either group. Cost analysis of our results estimated an average cost saving of approximately $127.75 per surgery when Prineo was used instead of subcuticular suture.
CONCLUSION:
In reduction mammoplasty, Prineo closure results in equivalent scar quality and lower operative cost without increased complications when compared to subcuticular closure. The Prineo system is significantly faster than subcuticular closure and represents an effective, consistent, and efficient alternative to standard suture techniques. 
Therapeutic Mammoplasty and

INTRODUCTION:
Breast reduction techniques in management of breast cancer have been described since 1980 mainly to resect large tumour in large breasts. This oncoplastic approach has emerged due to the demand for more aesthetically acceptable results without compromising oncological safety. In addition, the redundant lower pole breast skin envelope is used as a deepithelialized dermal flap. Recently published evidence has highlighted the importance of multidisciplinary thoracic oncoplastic approach in management of chest wall tumours providing a safe versatile long term outcome. We advocate a hybrid technique utilising both therapeutic mammoplasty and inferiorly based de-epithelialized dermal flap to provide coverage for anterior chest wall defects post resection of chest wall tumour which to the author's best knowledge would be the first time to be described in this context METHODS: Retrospective data analysis of 115 patients between 2009-2017 whom underwent chest wall resection and reconstruction revealed the utilization of therapeutic mammoplasty and dermal flap to provide soft tissue coverage post resection of chest wall sarcoma in 7 patients. Patient's demographics, clinico-pathological, radiological, operative details, adjuvant therapy, postoperative morbidity and follow-up data were recorded in these seven patients
RESULTS:
Chondrosarcoma was the pathology in all women with age range from 31-59 years (median 35). Defects were located anterior with size ranging from 100-150 cm2 (mean 115). The post-operative follow-up ranged from 36-72 months (median 17). R0 resection was achieved in all patients. Rigid reconstruction with cement mesh was performed in four patients while in three non-rigid reconstructions with prolene mesh was performed. Supero-medial nipple areola complex pedicle was performed in 5 unilateral while supero-lateral in a bilateral case and a unilateral case was performed. In all patients the lower pole de-epithelialized dermal flap was used to provide soft tissue coverage. Three patients had contralateral symmetrisation. One patient experienced T junction necrosis which was managed conservatively while all other patients had excellent functional and aesthetic outcomes CONCLUSION: Therapeutic mammoplasty and dermal flap as a hybrid technique would provide both an excellent exposure for resection and a versatile, easy and safe option for soft tissue coverage post chest wall resection with superior aesthetic outcomes. This technique should be added as a valuable tool in the armamentarium of thoracoplasty especially in young females with moderate to large breasts 
Outcomes of Sternal
